 effect tricycl antidepress opiat antagonist binge- behavior normoweight bulim obes binge- subject subset obes popul bing eat twice weekli binger person trait food attitud similar normoweight bulim women bulim tricycl antidepress opiat antagonist suppress bing normoweight bulim placebo-control double-blind trial effect naltrexon imipramin obes binger bulim naltrexon mg/d signific reduct bing durat bulim median siqr wherea bing durat obes binger strong placebo effect obes binger reduct bing frequenc naltrexon imipramin differ effect placebo control naltrexon imipramin use agent treatment bing eat